Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen-Reference-Cited by-同舟云学术

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen

Published:2003-05 Issue:8 Volume:17 Page:1167-1172
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Polis Michael A,Suzman Daniel L,Yoder Christian P,Shen Jean M,Mican JoAnn M,Dewar Robin L,Metcalf Julia A,Falloon Judith,Davey Richard T,Kovacs Joseph A,Feinberg Mark B,Masur Henry,Piscitelli Stephen C

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

2. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

3. Determination of an in vivo metabolite of a human immunodeficiency virus protease inhibitor in human plasma by high-performance liquid chromatography with tandem mass spectrometry

4. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

5. Cerebrospinal Fluid and Plasma Viral Load in HIV-1-infected Patients with Various Anti-retroviral Treatment Regimens

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study;Clinical Infectious Diseases;2021-11-08

2. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections;Viruses;2020-01-25

3. Antiretroviral Therapy: Brain Penetration;Global Virology II - HIV and NeuroAIDS;2017

4. Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations;Clinical Pharmacokinetics;2015-03-17

5. The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV;American Journal of Epidemiology;2014-06-24